Cargando…
Skin- and Plasmaautofluorescence in hemodialysis with glucose-free or glucose-containing dialysate
BACKGROUND: Haemodialysis (HD) patients suffer from an increased risk of cardiovascular disease (CVD). Skin autofluorescence (SAF) is a strong marker for CVD. SAF indirectly measures tissue advanced glycation end products (AGE) being cumulative metabolites of oxidative stress and cytokine-driven inf...
Autores principales: | Ramsauer, Bernd, Engels, Gerwin Erik, Graaff, Reindert, Sikole, Aleksandar, Arsov, Stefan, Stegmayr, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217331/ https://www.ncbi.nlm.nih.gov/pubmed/28056864 http://dx.doi.org/10.1186/s12882-016-0418-0 |
Ejemplares similares
-
Fatigue in Hemodialysis Patients With and Without Diabetes: Results From a Randomized Controlled Trial of Two Glucose-Containing Dialysates
por: Raimann, Jochen G., et al.
Publicado: (2010) -
Effects of Acetate-Free Citrate Dialysate on Glycoxidation and Lipid Peroxidation Products in Hemodialysis Patients
por: Masuda, Atsumi, et al.
Publicado: (2012) -
Conversion from acetate dialysate to citrate dialysate in a central delivery system for maintenance hemodialysis patients
por: Park, Eun ji, et al.
Publicado: (2019) -
Peritoneal Dialysate Glucose Load and Systemic Glucose Metabolism in Non-Diabetics: Results from the GLOBAL Fluid Cohort Study
por: Lambie, Mark, et al.
Publicado: (2016) -
Effect of dialysate potassium and lactate on serum potassium and bicarbonate concentrations during daily hemodialysis at low dialysate flow rates
por: Leypoldt, John K., et al.
Publicado: (2019)